openPR Logo
Press release

Investigation announced for Long-Term Investors in Progenity, Inc. (NASDAQ: PROG)

12-03-2020 02:48 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Progenity, Inc. (NASDAQ: PROG) shares.

An investigation on behalf of current long term investors in Progenity, Inc. (NASDAQ: PROG) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Progenity, Inc.

Investors who are current long term investors in Progenity, Inc. (NASDAQ: PROG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: PROG stocks follows a lawsuit filed against Progenity, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: PROG stocks, concerns whether certain Progenity directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that that the Registration Statement for the IPO was negligently prepared and, as a result, contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make the necessary disclosures required under the rules and regulations governing its preparation. Specifically,the plaintiff alleges that the Registration Statement failed to disclose, inter alia, the following adverse facts that existed at the time of the IPO, rendering numerous statements provided therein materially false and misleading, that Progenity had overbilled government payors by $10.3 million in 2019 and early 2020 and, thus, had materially overstated its revenues, earnings and cash flows from operations for the historical financial periods provided in the Registration Statement, that Progenity would need to refund this overpayment in the second quarter of 2020 (the same quarter in which the IPO was conducted), adversely impacting its quarterly results, and that Progenity was suffering from accelerating negative trends in the second quarter of 2020 with respect to the Company’s testing volumes, revenues and product pricing.

Those who purchased shares of Progenity, Inc. (NASDAQ: PROG) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Progenity, Inc. (NASDAQ: PROG) here

News-ID: 2201861 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Progenity

Rare Disease Testing Market Revenue, Key Findings and Forecast 2021-2026 | Preve …
The latest research report on the Rare Disease Testing Market by MarkNtel Advisors drafts an extensively detailed analysis of the different trends, drivers, restraints, challenges, and opportunities for the stakeholders to make informed decisions in the future. The report is to benefit the leaders by using the integrated market report using the advantageous information, including the impact of Covid-19. While the pandemic affected the world drastically and has brought along
Noninvasive Prenatal Testing (NIPT) Market to Witness Strong Growth by 2028 | Co …
Noninvasive Prenatal Testing (NIPT) Market research report identifies key market trends and focuses on the significant trends and factors driving the market growth. In addition, it analyses the global and key regions' market potentials and advantages, opportunities and challenges, restraints and risks. Finally, the Noninvasive Prenatal Testing (NIPT) Market research report strategically analyzes each submarket concerning market growth trends and their contribution. In addition, the Noninvasive Prenatal Testing (NIPT) Market
United States Non-Invasive Prenatal Testing Market Key Players Illumina, Natera, …
The United States Non-Invasive Prenatal Testing (NIPT) market is expected to touch a valuation of USD 2.5 Billion by 2028. The U.S. Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods
Deadline on Oct. 27th coming up in Lawsuit for Investors in Progenity, Inc. (NAS …
A deadline is coming up on October 27, 2020 in the lawsuit filed for certain investors of Progenity, Inc. (NASDAQ: PROG) over alleged securities laws violations by Progenity, Inc. Investors who purchased shares of Progenity, Inc. (NASDAQ: PROG) have certain options and there are strict and short deadlines running. Deadline: October 27, 2020. NASDAQ: PROG stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of Progenity, Inc. (NASDAQ: PROG)
An investor, who purchased shares of Progenity, Inc. (NASDAQ: PROG), filed a lawsuit over alleged violations of Federal Securities Laws by Progenity, Inc. in connection with Progenity’s June 2020 initial public offering ("IPO"). Investors who purchased shares of Progenity, Inc. (NASDAQ: PROG) have certain options and for certain investors are short and strict deadlines running. Deadline: October 27, 2020. NASDAQ: PROG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call
Investigation for Investors in shares of Progenity, Inc. (NASDAQ: PROG) announce …
An investigation was announced on behalf of investors of Progenity, Inc. (NASDAQ: PROG) shares over potential securities laws violations by Progenity, Inc. in connection with certain financial statements. Investors who purchased shares of Progenity, Inc. (NASDAQ: PROG), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Progenity, Inc. (NASDAQ: PROG